Key Points

>The FDA granted Pfizer and BioNTech full U.S. approval of their Covid-19 vaccine.

>The move may encourage some unvaccinated Americans to get the shots as well as give more private businesses across the nation greater confidence to implement vaccine mandates.

>Up until now, the mRNA vaccine was on the U.S. market under an Emergency Use Authorization.

The Food and Drug Administration on Monday granted full approval Monday to Pfizer and BioNTech Covid-19 vaccine – becoming the first in the U.S. to win the coveted designation and giving even more businesses, schools and universities greater confidence to adopt vaccine mandates.